Evaxion AS (EVAX)

3.25 +0.14 (+4.50%) USD  |  NASDAQ  |  Mar 05, 10:46
More

Evaxion Payables and Accrued Expenses (Quarterly)

Payables and Accrued Expenses (Quarterly) Chart

View Payables and Accrued Expenses (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Payables and Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Payables and Accrued Expenses (Quarterly) Benchmarks

View Payables and Accrued Expenses (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S Upgrade
Ascendis Pharma A/S --
DBV Technologies SA Upgrade
Cellectis SA Upgrade
Akari Therapeutics Plc Upgrade